Search
Zelatriazin
go.drugbank.com/drugs/DB21647ExperimentalZelatriazin is a small molecule drug. Zelatriazin has a monoisotopic molecular weight of 392.11 Da.
Rivasterat
go.drugbank.com/drugs/DB21668ExperimentalRivasterat is a small molecule drug. Rivasterat has a monoisotopic molecular weight of 626.38 Da.
Laroprovstat
go.drugbank.com/drugs/DB21690InvestigationalLaroprovstat is a small molecule drug. Laroprovstat has a monoisotopic molecular weight of 414.16 Da.
Lecufexor
go.drugbank.com/drugs/DB21714ExperimentalLecufexor is a small molecule drug. Lecufexor has a monoisotopic molecular weight of 618.05 Da.
Matsupexole
go.drugbank.com/drugs/DB21715ExperimentalMatsupexole is a small molecule drug. Matsupexole has a monoisotopic molecular weight of 446.25 Da.
Balinatunfib
go.drugbank.com/drugs/DB21728InvestigationalBalinatunfib is a small molecule drug. Balinatunfib has a monoisotopic molecular weight of 502.19 Da.
Rogocekib
go.drugbank.com/drugs/DB21739InvestigationalRogocekib is a small molecule drug. Rogocekib has a monoisotopic molecular weight of 408.15 Da.
Thienylfentanyl
go.drugbank.com/drugs/DB09180ExperimentalIllicitThienylfentanyl is a fentanyl analog analgesic that was sold on the black market in the 1980s until the Federal Analog Act scheduled drugs based on structural similarity rather than scheduling drugs individually … Thienylfentanyl has a similar synthesis pathway to fentanyl except 2-(2-bromoethyl)thiophene is substituted for phenethyl bromide.
Bizalimogene ralaplasmid
go.drugbank.com/drugs/DB16113InvestigationalBizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related … Anal or Anal/peri-anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2).
Magrolimab
go.drugbank.com/drugs/DB16225InvestigationalMagrolimab is under investigation in clinical trial NCT02953782 (Trial of Magrolimab (Hu5f9-g4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer).